TABLE 3

Adherence to LTBI Treatment and Associated Factors Among Schoolchildren (Among Those Started on LTBI Treatment [n = 377])

VariableORAdjusted ORaAdjusted OR 95% CI
Gender, male0.720.760.47–1.23
Age, >12 y old0.820.880.54–1.43
Region of origin
    North America/Western Europe1.00 (reference)1.00 (reference)
    Developing countries/countries of former Soviet bloc1.020.810.27–2.50
Time since arrival in Canada
    <2 y1.00 (reference)1.00 (reference)
    ≥2 y1.071.160.58–2.31
BCG vaccination1.24NA
Previous TST1.04NA
Abnormal chest radiograph1.731.510.73–3.14
Adverse effects from treatment1.191.190.44–3.20
No. of family members screened
    0–11.00 (reference)1.00 (reference)
    ≥22.20b2.041.26–3.30
  • OR indicates odds ratio; CI, confidence interval; NA, not applicable.

  • a Adjusted for age, gender, region of origin, time in country, chest radiograph status, treatment adverse effects, and number of family members screened.

  • b P > .01.